The effect of the 12-kDa isoform of FK-506 -binding protein (FKBP)12.0 on cardiac excitationcontraction coupling was studied in adult rabbit ventricular myocytes after transfection with a recombinant adenovirus coding for human FKBP12.0 (Ad-FKBP12.0). Western blots confirmed overexpression (by 2.6Ϯ0.4 fold, nϭ5). FKBP12.0 association with rabbit cardiac ryanodine receptor (RyR2) was not detected by immunoprecipitation. However, glutathione S-transferase pull-down experiments indicated FKBP12.0 -RyR2 binding to proteins isolated from human and rabbit but not dog myocardium. Voltage-clamp experiments indicated no effects of FKBP12.0 overexpression on L-type Ca 2ϩ current (I Ca,L ) or Ca 2ϩ efflux rates via the Na ϩ /Ca 2ϩ exchanger. Ca 2ϩ transient amplitude was also not significantly different. However, sarcoplasmic reticulum Ca 2ϩ load was Ϸ25% higher in myocytes in the Ad-FKBP12.0 group. The reduced ability of I Ca,L to initiate sarcoplasmic reticulum Ca 2ϩ release was observed over a range of values of sarcoplasmic reticulum Ca 2ϩ content, indicating that overexpression of FKBP12.0 reduces the sensitivity of RyR2 to Ca 2ϩ . Ca 2ϩ spark morphology was measured in ␤-escin-permeabilized cardiomyocytes. Ca 2ϩ spark amplitude and duration were significantly increased, whereas frequency was decreased in cells overexpressing FKBP12.0. These changes were accompanied by an increased sarcoplasmic reticulum Ca 2ϩ content. In summary, the effects of FKBP12.0 overexpression on intact and permeabilized cells were similar to those of tetracaine, a drug known to reduce RyR2 Ca 2ϩ sensitivity and distinctly different from the effects of overexpression of the FKBP12.6 isomer. In conclusion, FKBP12.0-RyR2 interaction can regulate the gain of excitation-contraction coupling. (Circ Res.
C a 2ϩ release via the sarcoplasmic reticulum (SR) Ca 2ϩ release channel (ryanodine receptor [RyR2]) is modulated by regulatory proteins interacting with both the cytoplasmic and luminal aspects of RyR2. One such cytosolic protein is FK-506 -binding protein (FKBP), which binds to the RyR2 with a maximum stoichiometry of 4 FKBP:1 RyR2. 1 Two members of the FKBP family are expressed within mammalian ventricular cardiomyocytes: FKBP12.0 (12.0 kDa) and FKBP12.6 (12.6 kDa). The cytosolic concentration of FKBP12.0 is almost 10-fold higher than FKBP12.6. 1, 2 In some species (eg, canine), the affinity of FKBP12.0 for RyR2 is Ϸ500 times lower than for FKBP12.6, hence binding is negligible under physiological conditions. 1 In others (including rabbit and human), the affinity of FKBP12.0 for RyR2 is only Ϸ7 times lower than for FKBP12.6 1 ; therefore, it is conceivable that FKBP12.0 -RyR2 interaction occurs in these species under physiological conditions. 1 The consequences of FKBP12.0 binding on RyR2 function are unclear; currently, no pharmacological intervention can differentiate between the effects of FKBP12.0 and -12.6. FKBP12.0-null mice showed RyR2 dysfunction 3 either resulting from the absence of RyR2-FKBP12.0 binding or as an indirect consequence of the accompanying developmental defects. FKBP12.6-null mice lack developmental defects, supporting the view that the FKBP12.0 isoform is indispensable for normal cardiac development. In the current study, adenoviral-mediated transfection of the human FKBP12.0 gene was used to overexpress FKBP12.0 in isolated rabbit ventricular cardiomyocytes over 48 hours. The choice of rabbit heart tissue was based on the similarities to human heart in terms of relative affinities of FKBP12.0 and FKBP12.6 for RyR2.
Materials and Methods

Recombinant Adenovirus Vector Construction
Full-length cDNA of the human FKBP12.0 gene was cloned by polymerase chain reaction (PCR) from human heart muscle-specific cDNA samples by the use of PCR primers that span the entire coding region of FKBP12.0 cDNA. This sequence was inserted downstream from a cytomegalovirus promoter into vector pACCMV ⅐ pLpA, and recombination with vector pJM17 was performed in HEK293 cells. The production, purification, and titration of adenovirus containing the FKBP12.0 gene (Ad-FKBP12.0) were performed according to standard procedures. 4 Previous studies have used an adenovirus containing the human FKBP12.6 gene. 2, 5 At 100 multiplicities of infection, this Ad-FKBP12.6 vector caused an overexpression of FKBP12.6 of Ϸ6-fold normal values after 48 hours of incubation.
Ventricular Cardiomyocyte Isolation and Transfection
New Zealand White rabbits (2 to 2.5 kg) were euthanized by administration of an intravenous injection of 500 IU heparin, together with an overdose of sodium pentobarbitone (100 mg ⅐ kg Ϫ1 ). Hearts were removed in accordance with the United Kingdom Animals (Scientific Procedures) Act 1986 and conformed to the Guide for the Care and use of Laboratory Animals (NIH publication no. 85-23, revised 1985). Ventricular cardiomyocytes were then isolated as described previously. 5 Adenoviral infection with a multiplicity of infection of 100 was performed to produce 2 populations of adenovirus-transfected cardiomyocytes: (1) overexpressing FKBP12.0 (Ad-FKBP12) and (2) expressing ␤-galactosidase as control (Ad-LacZ). Infected cardiomyocytes were subsequently cultured in supplemented medium M199 (Sigma) for 48 hours. Western blot analysis indicated the level of FKBP12.0 overexpression to be 2.6Ϯ0.4-fold (nϭ5, PϽ0.05) higher compared with nontransfected control cells.
Glutathione S-Transferase Pull-Down Assay
Prepared cell lysates and cardiac homogenates were incubated with 30 g of glutathione S-transferase (GST)-FKBP12.0 or GST-FKBP12.6 immobilized on glutathione-sepharose for 5 hours at 4°C. Human FKBP12-pGEX-3X or FKBP12.6-pGEX-3X constructs (generously provided by Dr Wayne Chen, Department of Physiology and Biophysics, University of Calgary, Canada) were used to express and purify the GST-FKBP12.0 and GST-FKBP12.6 according to the instructions of the manufacturer (Amersham). After washing the glutathione-sepharose precipitates 3 times in solubilization medium, the GST-tagged protein and any associated proteins were competitively eluted with 10 mmol/L reduced glutathione in 50 mmol/L Tris-HCl, pH 8.0, for 15 minutes at room temperature. Incubation of samples with immobilized GST (Sigma) and elution with 60 mol/L FK-506 or vehicle alone served as controls.
Immunoblot Analysis
FKBP12.0 from cell lysates was analyzed by 15% SDS-PAGE. Eluates obtained during GST pull-down assay were size fractionated on 4% to 20% SDS-PAGE. The immunoblotting procedure was performed as described previously. 2
Electrophysiological Measurements in Rabbit Cardiomyocytes
The isolated cardiomyocytes were superfused with a Krebs-Henseleit solution with additional 5 mol/L tetrodotoxin, 0.1 mmol/L niflumic acid, and 5 mmol/L 4-aminopyridine at 19 to 20°C in a chamber mounted on the stage of an inverted microscope (see the online supplement at http://circres.ahajournals.org for details about solutions, including pipette solutions). Cytosolic loading of Fura-2 was achieved by incubating cardiomyocytes with 5 mol/L Fura-2/ acetoxymethyl ester at room temperature for 12 minutes.
Excitation-Contraction Coupling Protocol
Using an Axon Instruments Switch-clamp (2B), cardiomyocytes were held at Ϫ80 mV and the voltage was stepped to Ϫ40 mV (50 ms) to inactivate the remaining inward Na ϩ current, stepping to 0mV (150 ms) before returning to -80 mV. This protocol was repeated every 2s for 80s to achieve steady-state Ca 2ϩ transients. SR Ca 2ϩ content and Na ϩ /Ca 2ϩ exchanger (NCX) activity were then estimated by rapidly switching to 10 mmol/L caffeine to cause SR Ca 2ϩ release. In the continued presence of caffeine, the SR is unable to reaccumulate Ca 2ϩ and elimination of Ca 2ϩ is mainly attributable to NCX. The time course of the decay of [Ca 2ϩ ] and I NCX represent rates of extrusion of Ca 2ϩ from the cell predominately by NCX. 6 These signals were fitted to exponential decays Ͼ80% of their amplitude.
The relationship between SR Ca 2ϩ content and Ca 2ϩ transient amplitude at low SR Ca 2ϩ loads was investigated by manipulating SR Ca 2ϩ content. Reduction of SR Ca 2ϩ content was achieved by superfusing cardiomyocytes for set periods of time with thapsigargin (5 mol/L). 7 Increased SR Ca 2ϩ content was achieved with a holding potential of Ϫ50 mV between voltage-clamp pulses.
Ca 2؉ Spark Measurements in Permeabilized Cardiomyocytes
Isolated rabbit cardiomyocytes were superfused with a mock intracellular solution and permeabilized using ␤-escin (Sigma) as detailed previously. 5 Fluo-3 (10 mol/L) in the perfusing solution was excited using a confocal microscope. Confocal line scan images were recorded using a Bio-Rad Radiance 2000 confocal system, further details of which have been published previously. 5 All Ca 2ϩ spark measurements were made within 2 to 3 minutes of cell permeabilization.
Statistics
Data were expressed as meansϮSEM. For ionic currents, intracellular [Ca 2ϩ ], and Ca 2ϩ spark parameters, comparisons were performed by using the unpaired Student's t test; otherwise, the paired Student's t test was used. Differences were considered significant when PϽ0.05. ANOVA statistics with a Tukey post test were used in cases of multiple comparisons.
Results
Overexpression of FKBP12.0 Within Isolated Adult Rabbit Ventricular Cardiomyocytes
Transgene expression at mRNA and protein levels were verified by means of RT-PCR and immunoblotting, respectively, both of which revealed a specific dose-dependent increase of exogenous FKBP12.0 ( Figure 1A through 1C). To ensure effective overexpression of the transgene, cells were transfected at a multiplicity of infection of 100, which provides a moderate increase of the exogenous FKBP12.0 to 2.6Ϯ0.4 (nϭ5) fold above normal.
[Ca 2؉ ] i Measurements in Voltage-Clamped Rabbit Cardiomyocytes
No significant change in Ca 2ϩ transient amplitude (231Ϯ15 versus 238Ϯ19 nmol/L; Ad-LacZ, nϭ33cells versus Ad-FKBP12, nϭ20cells) was observed in voltage-clamped rabbit cardiomyocytes ( Figure 2A and 2C, i). Similarly, no significant difference between the Ca 2ϩ decay of the Ca 2ϩ transient was noted between the 2 populations of cells, suggesting no effect of Ad-FKBP12.0 overexpression on SERCA-mediated SR Ca 2ϩ uptake ( Figure 2C , ii). This was supported by measurements of SERCA-mediated Ca 2ϩ uptake in oxalate equilibrated permeabilized cardiac myocytes after FKBP12.0 overexpression (data not shown). As illustrated in Figure 2A , I Ca,L amplitude was monitored by incorporating a prepulse to Ϫ40 mV for 50 ms to inactivate the small amount of remaining inward I Na (in the presence of 5 mol/L tetrodotoxin). In addition to the measurements of I Ca,L amplitude ( Figure 2B and 2D, i), the time integral of I Ca was calculated and converted to a Ca 2ϩ influx (normalized to cell capacitance; Figure 2D , ii). The amplitude of I Ca,L and the integral of the current were not different between the 2 experimental groups. This confirms the absence of an effect of FKBP12.0 overexpression on I Ca in these experiments.
SR Ca 2؉ Content as Assessed by Rapid Application of Caffeine
Application of caffeine caused a rapid increase of [Ca 2ϩ ] i as a result of SR Ca 2ϩ release, the subsequent reduction of which results from extrusion of Ca 2ϩ across the sarcolemma mainly via the NCX. This extrusion of Ca 2ϩ via NCX generates a transient inward current, the amplitude and time course of which was monitored together with the Ca 2ϩ transient ( Figure  3A and 3B). As shown in Figure 3A (mean values shown in Figure 3B , i), the amplitude of the caffeine-induced Ca 2ϩ release was significantly larger in Ad-FKBP12.0 -transfected cardiomyocytes, suggesting an increased SR Ca 2ϩ content (762Ϯ42 versus 910Ϯ74 nmol/L; Ad-LacZ [nϭ26 cells] versus Ad-FKBP12 [nϭ24 cells]). As described previously, 6 the time integral of the current can be used as a measure of the amount of Ca 2ϩ extruded by NCX during a caffeine application (an indicator of the SR Ca 2ϩ content). As shown in Figure  3B , iii, the mean integral of the NCX-mediated inward current (I NCX ) in the Ad-FKBP12.0 -transfected group was Ϸ25% higher than the control (Ad-LacZ) group (normalized to cell capacitance), supporting the conclusion that SR Ca 2ϩ content was significantly higher in the FKBP12.0overexpressing cardiomyocytes.
Sarcolemmal Ca 2؉ Efflux Rates in Rabbit Cardiomyocytes
Sarcolemmal flux rates can be estimated from the time course of the inward current decay and the corresponding decrease in [Ca 2ϩ ] after rapid application of 10 mmol/L caffeine. As shown in Figure 3C , i and ii, both I NCX and [Ca 2ϩ ] decayed with a similar time course in Ad-FKBP12.0-transfected cardiomyocytes. These decays were fitted to a single exponential function, and mean rate constants were calculated. The rate constants for both parameters were not significantly different in the 2 experimental groups, suggesting that the rate of extrusion of Ca 2ϩ via the NCX was not affected by FKBP12.0 overexpression.
Relationship Between SR Ca 2؉ Content and Ca 2؉ Transient Amplitude
To determine the relationship between the SR Ca 2ϩ content and Ca 2ϩ transient amplitude, measurements were made using thapsigargin to progressively decrease SR Ca 2ϩ content. A holding potential of Ϫ50 mV was used to increase SR Ca 2ϩ content. As shown in Figure 4 , the amplitude of I Ca,L was not altered by this range of experimental conditions. The plot of the I NCX integral and Ca 2ϩ transient amplitude for the Ad-LacZ group generated an approximately exponential relationship. The data from the Ad-FKBP12.0 group was shifted to the right and described an exponential curve that was significantly different from that required to fit the Ad-LacZ data ( Figure 4 ). Analysis of I Ca,L indicated that there were no significant changes in the amplitude or time course of this current in any of the datasets. Therefore, the exponential relationship described by the Ad-LacZ data represents the relationship between SR Ca 2ϩ content and the ability of I Ca,L to trigger Ca 2ϩ release from the SR, ie, excitation-contraction (E-C) coupling "gain." 8 Overexpression of FKBP12.0 moved this curve to the right, indicating a reduced gain of E-C coupling. A similar but larger effect was observed in a separate group of Ad-LacZ cells superfused with 100 mol/L tetracaine (a drug known to decrease the Ca 2ϩ sensitivity of RyR2). As can be seen in Figure 4 , this caused an increase in SR Ca 2ϩ content (2.2Ϯ0.14 versus 3.78Ϯ0.33 coulombs/ farad; Ad-LacZ [nϭ6 cells] versus Ad-LacZϮtetracaine [nϭ6 cells]) but no increase in Ca 2ϩ transient amplitude (231Ϯ14 versus 232Ϯ53 nmol/L; nϭ6 cells). Data obtained from parallel studies using a previously characterized Ad-FKBP12.6 virus 5 are shown in gray. As reported previously, FKBP12.6 overexpression significantly increased the Ca 2ϩ amplitude and SR Ca 2ϩ content, 5 with no obvious shift from the 
Interaction of FKBP12.0 and FKBP12.6 With RyR2
Previously published work based on immunoprecipitation experiments suggests interaction of RyR2 with FKBP12.6. 9 The present study used similar immunoprecipitation techniques to confirm FKBP12.6 binding but could not detect specific interaction of FKBP12.0 with RyR2 ( Figure I in the online data supplement). To further examine the interaction between FKBP12.0 and RyR2, GST pull-down assays were performed. GST fusion FKBP12.0 and FKBP12.6, immobilized on glutathione-sepharose beads, were allowed to interact with solubilized proteins of cell lysates and cardiac homogenates. The resulting complexes were then visualized by immunoblotting and silver staining. Figure 5A shows the extraction of rabbit RyR2 using GST-FKBP12.0 and GST-FKBP12.6 immobilized on glutathione-sepharose. RyR2, shown in lanes 3 and 4, was precipitated on the basis of its association with GST-FKBP12.0 and GST-FKBP12.6, respectively. The retained RyR2 was specifically bound to GST-FKBP12.0 because GST alone did not bind any RyR2 ( Figure 5A , i and iii, lane 5). Furthermore, from 1 of the precipitates formed after interaction with GST-FKBP12.0, RyR2 was eluted with 60 mol/L FK-506 (instead of 10 mmol/L glutathione) as a specific competitor ( Figure 5A , i and iii, lane 7). To clarify whether FK-506 removed all of RyR2 from the immobilized FKBP12.0 ( Figure 5C , i and ii, lane 1), GST-FKBP12.0, still bound to the glutathionesepharose after application of FK-506, was eluted with reduced glutathione ( Figure 5C, lane 2) . The absence of RyR2 in this fraction, as revealed by silver staining (Figure 
Canine RyR2 Interacts Exclusively With the FKBP12.6 Isoform
When subjected to the GST pull down, canine RyR2 was able to interact with GST-FKBP12.6 ( Figure 5D , i and iii, lane 6) but not with GST-FKBP12.0 ( Figure 5D , i and iii, lane 3), whereas rabbit RyR2, probed in parallel, interacted with both GST-FKBP12.0 ( Figure 5C , i and iii, lane 8) and GST-FKBP12.6 ( Figure 5D , i and iii, lane 9). Analysis of the same precipitates by Western blot revealed that all canine RyR2 molecules subjected to interaction with GST-FKBP12.0 remained unabsorbed, because it was completely recovered in the flow-through fraction ( Figure 5D , iii, lane 1). In contrast, GST-FKBP12.6 provided efficient extraction of RyR2 from the crude homogenate ( Figure 5D, iii, lanes 4 and 6) . . The data are from cardiomyocytes from the control group (Ad-LacZ) (nϭ10); 5 mol/L thapsigargin, 20-second exposure (nϭ8); 40-second exposure (nϭ8); 100second exposure (nϭ8); holding potential of Ϫ50 mV (nϭ10) and Ad-FKBP12 (nϭ10); 5 mol/L thapsigargin, 20-second exposure (nϭ8); 40-second exposure (nϭ7); 100-second exposure (nϭ8); holding potential of Ϫ50 mV (nϭ8). Gray symbols are the data from parallel experiments in an adenoviral vector for FKBP12.6 (Ad-FKBP12.6) and the corresponding Ad-LacZ data (nϭ10 and nϭ12.0, respectively). Solid lines are leastsquares best-fit exponential relationship (Yϭexp[ϪGϫX]), where Y is the Ca 2ϩ transient amplitude and X is the I NCX integral. The best-fit value of coefficient G for the FKBP12.0 dataset was significantly lower than LacZ (1.69Ϯ0.11 vs 1.09Ϯ0.05; PϽ0.01).
Ca 2؉ Sparks and Caffeine-Induced Ca 2؉ Release in Permeabilized Cardiomyocytes Overexpressing FKBP12.0
An investigation of the direct effects of FKBP12.0 overexpression on Ca 2ϩ sparks in intact rabbit cardiomyocytes is complicated by the rapid sarcolemmal extrusion of intracellular Ca 2ϩ and reduction of resting [Ca 2ϩ ] and SR Ca 2ϩ content during the quiescent periods required for Ca 2ϩ spark recording. For this reason, sarcolemmal fluxes were functionally bypassed by the acute permeabilization of the sarcolemma with ␤-escin and the cytosolic [Ca 2ϩ ] maintained at 155 to 165 nmol/L. Ca 2ϩ spark activity and SR Ca 2ϩ content was monitored by the inclusion of 10 mol/L Fluo-3 in the perfusing solution. SR Ca 2ϩ content was assessed at the end of spark recording by rapid application of 10 mmol/L caffeine; the mean values are shown in Figure 6B . SR Ca 2ϩ content was significantly higher in cells transfected with Ad-FKBP12. (627Ϯ94 versus 1901Ϯ338 nmol/L; Ad-LacZ [nϭ8 cells] versus Ad-FKBP12 [nϭ6 cells]). To quantify Ca 2ϩ spark activity, the line scan images ( Figure 6A ) were analyzed using an automated spark detection program. 10 The results collated from a number of cardiomyocytes are shown in Figure 6C . Increases in mean values of peak (1.96Ϯ0.03 versus 2.14Ϯ0.09 F/F 0 ) and duration (40.4Ϯ1.5 versus 47.3Ϯ2.1 ms) were observed (Ad-LacZ: nϭ18 cells, 1742 events; versus Ad-FKBP12: nϭ10 cells, 626 events). Spark frequency was significantly reduced (0.064Ϯ0.005 versus 0.047Ϯ0.005 events ⅐ m Ϫ1 ⅐ sec Ϫ1 ). Incubation of cells with rapamycin (3 mol/L) during the 48 hours of quiescent culture inhibited the ability of Ad-FKBP12.0 to alter Ca 2ϩ spark parameters ( Figure 6D ). To support the conclusion that these Ca 2ϩ spark characteristics were attributable a decreased Ca 2ϩ sensitivity of RyR2, Ad-LacZ transfected cells were equilibrated with 50 mol/L tetracaine. Under these conditions the SR Ca 2ϩ content in these cells increased to similar levels observed in FKBP12.0 overexpressing cells (720Ϯ116 versus 1640Ϯ320 nmol/L, Ad-LacZ, nϭ10cells versus Ad-LacZϩTetracaine, nϭ10cells) as shown in Figure 7B . Ca 2ϩ spark parameters were also affected in a similar manner with increases in Ca 2ϩ spark peak (1.95Ϯ0.03 versus 2.05Ϯ0.04 F/F 0 ), duration (36.7Ϯ0.9 versus 40.58Ϯ1.8 ms), Ad-LacZ nϭ25 cells 2971 events; Ad-LacZ versus Ad-LacZϮtetracaine 
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nϭ11cells 1646 events) and a decrease in Ca 2ϩ spark frequency (0.062Ϯ0.004 versus 0.047Ϯ0.004 events ⅐ m Ϫ1 ⅐ sec Ϫ1 ). To compare the effects FKBP12.0 and tetracaine with previously published data on FKBP12.6 overexpression, 5 the relative effects of these interventions on peak, duration, width, and frequency of Ca 2ϩ sparks is shown in Figure 7D . The data are expressed relative to the corresponding Ad-LacZ (control) data. FKBP12.0 and tetracaine both caused an increase in peak and duration to Ϸ115% of control. As published previously, FKBP12.6 overexpression caused a decrease in peak and duration to Ϸ90% of control. All interventions decreased Ca 2ϩ spark frequency.
Discussion
Relationship Between Ca 2؉ Transient Amplitude and SR Ca 2؉ Content
This study is the first to show that overexpression of FKBP12.0 increases SR Ca 2ϩ content (by Ϸ25%) but does not alter Ca 2ϩ transient amplitude (Figures 2 and 3) . Previous studies have shown an approximately exponential relationship between SR Ca 2ϩ content and Ca 2ϩ transient amplitude. 11 In the present study, the Ad-LacZ group demonstrated a similar exponential relationship (Figure 4) , indicating that an Ϸ25% increase in SR Ca 2ϩ content would be expected to increase Ca 2ϩ transient amplitude by Ϸ100%. The absence of any significant effect on the Ca 2ϩ transient amplitude suggests that the sensitivity of the Ca 2ϩ -induced Ca 2ϩ release process is reduced by FKBP12.0 overexpression. 11 In support of this conclusion, tetracaine, a drug known to reduce the Ca 2ϩ sensitivity of RyR2, produced a similar effect on E-C coupling.
A previous study has shown that overexpressing FKBP12.6 increases Ca 2ϩ transient amplitude and SR Ca 2ϩ content. 5 Similar effects shown in the present study indicated that FKBP12.6 overexpression does not significantly affect E-C coupling gain (Figure 4) . In contrast, overexpression of FKBP12.0 reduced E-C coupling gain, suggesting that the 2 isoforms of FKBP may modulate RyR2 activity in different ways. This is reinforced by the contrasting effects of FKBP12.0 and 12.6 on Ca 2ϩ sparks. A more detailed study comparing the 2 isoforms is required to clarify this point further. 1 This work provided the first evidence that RyR2-FKBP12.0 interaction may occur in cardiac muscle in some vertebrates. The current study used immunoprecipitation techniques to demonstrate RyR2/FKBP12.6 association in rabbit heart cell lysates as previously reported in myocardium from rat and mice. 9 However, this technique failed to show RyR2/FKBP12.0 association. A GST pull- down assay involving purified proteins subsequently showed that both GST-FKBP isoforms were capable of binding with rabbit and human RyR2 ( Figure 5A and 5B ). In the immunoblot analysis that followed GST pull down, the anti-RyR antibody used could not discriminate between the 2 RyR isoforms. Recent data have demonstrated the coexpression of 3 different RyR isoforms in both healthy and failing human hearts. 12 In addition, possible contaminations of starting material with RyR1-containing cells/ tissue may also occur. MALDI-TOF mass spectrometry confirmed that the high-molecular-weight proteins precipitated with GST-FKBP12.0 was the cardiac isoform (RyR2). The reason for the discrepancy between immunoprecipitation and GST pull-down assays with regard to FKBP12.0/12.6-RyR2 interactions is unclear. The dichotomy would indicate that the nature of the interaction of the 2 FKBP isoforms with RyR2 is different. The association of FKBP12.6 appears to be more stable and capable of surviving the preparation of the tissue for biochemical studies. Although the functional data strongly indicate that FKBP12.0 affects RyR2 function, and the GST pull down indicates that direct FKBP12.0-RyR2 interaction is possible, the nature of the association may not be sufficiently strong to survive tissue preparation for immunoprecipitation studies.
Verification of RyR2-FKBP12.0 Interaction
Specificity and Reliability of GST Biochemical Data
To validate the specificity of the GST pull-down assay, canine RyR2 was used as a negative control. When subjected to the GST pull-down assay, canine RyR2 was able to interact with GST-FKBP12.6 but not with GST-FKBP12.0 ( Figure 5D ). This result supplements previously published data suggesting that canine RyR2 has a higher specificity for FKBP12.6 over FKBP12.0 compared with other mammals. 1
Effect of FKBP12.0 Overexpression on Ca 2؉ Sparks
Steady-state Ca 2ϩ spark activity and SR Ca 2ϩ load was measured in permeabilized cardiomyocytes at a standardized bathing [Ca 2ϩ ] (155 to 165 nmol/L). 13, 14 Previous work has established that Ca 2ϩ spark characteristics (amplitude, time course, and frequency) in permeabilized cells are indistinguishable from those observed in intact cells 14 and regulated by known modulators of RyR2 activity (Ca 2ϩ -calmodulin and cyclic ADPribose). 14 It is unlikely that there was any loss of FKBP from permeabilized preparations because previous work on isolated SR vesicles indicates minimal FKBP loss even after vigorous homogenization procedures. 15 FKBP12.0 overexpression resulted in a significantly increased steadystate SR Ca 2ϩ load in permeabilized cells. This confirmed the 
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conclusion that FKBP12.0 overexpression acted directly on the SR and not via sarcolemmal-based processes. The relative effect of FKBP12.0 overexpression on SR content was greater than that seen in intact cells. This may reflect the higher cytoplasmic [Ca 2ϩ ] and higher SR loads observed in the permeabilized cell experiments. Ca 2ϩ sparks were significantly increased in amplitude (Ϸ110%) and duration (Ϸ114%), but frequency was reduced (Ϸ73%) compared with control. These effects were prevented by preincubation with rapamycin. The changes in Ca 2ϩ spark characteristics are unlikely to be a simple consequence of the increased SR Ca 2ϩ content because manipulations that increase SR Ca 2ϩ content by stimulating the SR Ca 2ϩ pump increase both Ca 2ϩ spark size and frequency. 13 In the present study, SR Ca 2ϩ content was increased by inhibition of RyR2 using tetracaine (50 mol/L); this increased Ca 2ϩ spark amplitude (Ϸ106%) and duration (Ϸ111%) but reduced Ca 2ϩ spark frequency (Ϸ76%). The similarity of the changes in Ca 2ϩ spark parameters produced by tetracaine to those of the Ad-FKBP12.0 group supports the conclusions from the E-C coupling studies (Figure 4 ), namely that FKBP12.0 overexpression acts to reduce the overall Ca 2ϩ sensitivity of RyR2. This effect is distinct from the effect of FKBP12.6 overexpression reported earlier 5 and summarized in Figure 7D , ie, a decrease in spark peak and duration to Ϸ90% of control. This reinforces the point that the two forms of FKBP have differing effects on RyR2.
Does FKBP12.0 Influence E-C Coupling Under Physiological Conditions?
In rabbit cardiomyocytes, FKBP12.0 protein expression is Ϸ10 times higher than that of FKBP12.6. 2 The affinity of FKBP12.0 for rabbit RyR2 was estimated as Ϸ7 times lower than FKBP12.6 1 ; therefore, under physiological conditions, FKBP12.0 bound to RyR2 may be comparable to FKBP12.6. Under resting conditions, FKBP12.6 knockout mice appear to have a functional Ca 2ϩ -induced Ca 2ϩ release mechanism. 16 However, work on isolated RyR2 in lipid bilayers has shown that complete absence of FKBP12.6 and 12.0 from RyR2 causes dramatic increases in open probability and uncoupling of channels, 17 behavior that is not compatible with normal E-C coupling. This paradox may be explained by the retention of the influence of FKBP12.0 on RyR2 in animals without the FKBP12.6 isoform.
Conclusions
This study provides the first evidence that FKBP12.0 influences RyR2 function in a distinct fashion from that observed with FKBP12.6. The differences are summarized as follows.
(1) Unlike FKBP12.6, the association of FKBP12.0 to RyR2 could not be detected by immunoprecipitation but was evident in GST pull-down assays. (2) FKBP12.0 overexpression reduces the gain of E-C coupling, an effect not observed with FKBP12.6 overexpression. (3) FKBP12.0 overexpression increases Ca 2ϩ spark amplitude, the opposite from that observed with FKBP12.6. The molecular actions of FKBP on RyR are not clear; changes in isolated RyR2 channel kinetics have been observed as a result of FKBP12.6 binding. 18 FKBP12.6 is also thought to mediate the coupled gating observed in RyR2 channel clusters. 19 These data suggest that the net effect of FKBP12.6 on a cluster of RyR2s in the dyad is therefore a combination of at least 2 effects. One possible explanation for the distinct effects of FKBP12.0 observed in this study is a different balance of effects on the singlechannel kinetics and interchannel cooperatively. But there is, as yet, no evidence to suggest that FKBP12.0 and FKBP12.6 act on the same site on RyR2. Further studies of FKBP12.0and FKBP12.6 -RyR2 interactions would benefit from a conditional FKBP12.6/FKBP12.0 knockout to circumvent the developmental cardiac defects observed in FKBP12.0 knockout mice and allow the effects of FKBP12.6 and FKBP12.0 to be studied in isolation.
